For most people who land on this comparison, the choice between the Parkinsons Protocol and Neuropathy No More is not a matter of preference — it is determined by diagnosis. These two Blue Heron Health News programs address fundamentally different nerve conditions with different mechanisms, different anatomical territories, and different lifestyle management priorities. If you have a Parkinson’s disease diagnosis, the Parkinsons Protocol is the relevant program. If you have Type 2 diabetes with peripheral neuropathy, Neuropathy No More is the relevant program. This article exists to explain why the distinction matters, help you identify which side of the line you are on, and give you the full picture of both programs so that decision is straightforward. The focus here is primarily on the Parkinsons Protocol as the resource for people navigating Parkinson’s disease.
TL;DR
- These programs target completely different conditions — Parkinson’s disease (a progressive neurodegenerative brain disorder) and diabetic peripheral neuropathy (a metabolic complication of Type 2 diabetes damaging peripheral nerves in the extremities) are not variations of the same problem
- Parkinsons Protocol is for people with a confirmed Parkinson’s disease diagnosis; it addresses dopamine-supportive nutrition, neuroprotective lifestyle strategies, movement and exercise protocols calibrated to Parkinson’s motor challenges, and gut-brain axis support
- Neuropathy No More is for people with Type 2 diabetes who have developed peripheral neuropathy; it addresses blood sugar regulation, circulation to peripheral nerves, and nerve-repair nutritional support
- Both published by Blue Heron Health News — same publisher, same philosophy, one-time digital purchase (~$49 each), and Blue Heron’s full 365-day money-back guarantee
- Diagnosis determines the choice — not symptom similarity; both can cause fatigue, balance difficulties, and nerve pain, but their root causes require completely different approaches
- Decision tree: Parkinson’s diagnosis → Parkinsons Protocol; T2D + neuropathy symptoms → Neuropathy No More; both conditions → both programs; unsure of diagnosis → see a doctor first
Visit the Official Parkinsons Protocol Site — 365-Day Guarantee
1. Why This Comparison Exists
When someone searches “Parkinsons Protocol vs Neuropathy No More,” they are usually in one of two situations. Either they are experiencing overlapping nerve symptoms — tremor, tingling, burning, weakness — and are uncertain which condition they may have, or they have a loved one with one of these conditions and have encountered both programs in their research. In rarer cases, a person genuinely has both conditions and is trying to understand whether they need one program or two.
The confusion is understandable. Both programs come from Blue Heron Health News. Both appear in health forums and review sites under the general category of “natural nerve programs.” Both use lifestyle and dietary approaches. Both carry the same 365-day guarantee. And both address conditions that — in common speech — people describe as “nerve problems.”
But the similarity ends there. The nerve conditions these programs target have different causes, different affected anatomical locations, different symptom patterns, and different management priorities. A person with Parkinson’s disease and a person with diabetic peripheral neuropathy are not experiencing different intensities of the same problem. They have different diseases.
The most useful thing this comparison can do is make that distinction absolutely clear — and then show you where the Parkinsons Protocol fits in the picture for people navigating Parkinson’s disease.
2. Parkinson’s Disease vs Peripheral Neuropathy: The Critical Difference
Before comparing the programs, you need to understand the conditions. This section covers the biology cleanly, without jargon overload, so that the program choice becomes obvious.
Parkinson’s Disease: A Neurodegenerative Brain Condition
Parkinson’s disease is a progressive neurodegenerative movement disorder. It develops when a specific population of neurons — the dopaminergic neurons in the substantia nigra pars compacta, a small region deep in the midbrain — progressively degenerate and die. These neurons project to the striatum (part of the basal ganglia) via the nigrostriatal pathway, releasing dopamine that enables smooth, coordinated movement. When approximately 60–70% of these neurons have been lost, the characteristic motor features of Parkinson’s emerge.
The molecular hallmark of Parkinson’s disease is the Lewy body: abnormal aggregates of misfolded alpha-synuclein protein that accumulate inside neurons and appear directly toxic to them. Oxidative stress, mitochondrial dysfunction — specifically Complex I deficiency in the electron transport chain — and neuroinflammation involving microglia are all implicated in the degeneration process.
Cardinal motor features of Parkinson’s disease:
- Resting tremor — the most recognised feature; a 4–6 Hz tremor typically beginning in one hand (the “pill-rolling” tremor between thumb and forefinger) that diminishes during intentional movement and stops during sleep
- Bradykinesia — slowness of movement and difficulty initiating movement; reduced arm swing when walking; micrographia (small, cramped handwriting); hypophonia (soft voice)
- Rigidity — cogwheel or lead-pipe resistance to passive limb movement during examination
- Postural instability — impaired balance reflexes, a significant contributor to falls; typically emerges in later disease stages
Non-motor features — now understood to be as clinically significant as the motor features — include: REM sleep behaviour disorder (often a prodromal marker preceding motor symptoms by years), anosmia (reduced sense of smell), constipation, depression and anxiety, autonomic dysfunction, and in advanced stages, cognitive impairment. Parkinson’s disease is progressive and typically presents in people over 60, though early-onset Parkinson’s exists.
Critically: Parkinson’s disease is a condition of the central nervous system — specifically the midbrain. It is not primarily a peripheral nerve disease, though autonomic neuropathy can co-occur in some people with Parkinson’s.
Diabetic Peripheral Neuropathy: A Metabolic Complication
Diabetic peripheral neuropathy is nerve damage caused by chronically elevated blood glucose in people with Type 2 diabetes (and sometimes Type 1). It is the most common complication of diabetes, affecting an estimated 50% of people with longstanding T2D. It is a condition of the peripheral nervous system — the nerves outside the brain and spinal cord.
The mechanism is primarily vascular. Peripheral nerves — particularly the long nerves supplying the feet and hands — receive their oxygen and nutrients from a network of tiny blood vessels called the vasa nervorum. Chronically elevated blood sugar damages these vessels through overlapping pathways: advanced glycation end-products stiffen vessel walls; oxidative stress damages vascular endothelium; sorbitol accumulation creates osmotic stress in nerve cells. The result is progressive reduction in blood supply to peripheral nerve fibers, which begin to deteriorate from deprivation.
Symptoms begin in the feet — the longest nerves, most vulnerable to circulatory compromise — and ascend upward in a classic “stocking-glove” distribution:
- Burning pain in the soles of the feet, often worse at night
- Tingling and pins-and-needles sensations in the toes, feet, and fingers
- Electric shock sensations that occur spontaneously
- Numbness and loss of sensation — initially fine-touch, then protective pain sensation
- Loss of proprioception and balance difficulties
- In advanced cases, foot ulceration due to unnoticed minor injuries
This is the condition that Neuropathy No More addresses — and its approach flows directly from this mechanism. The single most evidence-supported intervention for slowing diabetic peripheral neuropathy is glycemic control: keeping HbA1c within target range and reducing the glucose toxicity damaging peripheral nerve fibers.
Can You Have Both?
Yes — and this is an important point for some readers. Type 2 diabetes and Parkinson’s disease are independent conditions with separate pathophysiological mechanisms. A person with T2D who also develops Parkinson’s disease has two distinct diseases requiring two distinct management approaches. The co-occurrence is uncommon but not rare, particularly in older adults where both conditions are more prevalent.
In that scenario, both programs may be genuinely relevant — not as alternatives, but as separate tools for separate diseases.
Symptom vs Likely Condition
| Symptom | More Likely Condition | Relevant Program |
|---|---|---|
| Resting tremor in one hand (pill-rolling, stops with movement) | Parkinson’s disease | Parkinsons Protocol |
| Slowness of movement, reduced arm swing when walking | Parkinson’s disease | Parkinsons Protocol |
| Muscle stiffness, cogwheel rigidity | Parkinson’s disease | Parkinsons Protocol |
| Loss of smell + constipation + acting out dreams during sleep | Prodromal Parkinson’s | Seek neurological evaluation |
| Burning/tingling in both feet, worse at night | Diabetic peripheral neuropathy (if T2D present) | Neuropathy No More |
| Numbness in toes/fingers, “stocking-glove” distribution | Diabetic peripheral neuropathy | Neuropathy No More |
| Loss of sensation in feet (injuries unnoticed) | Advanced diabetic neuropathy | Neuropathy No More + urgent medical review |
| Fatigue + balance difficulty without clear diagnosis | Could be either — requires medical evaluation | Seek diagnosis first |
Note: This table is for orientation only. Definitive diagnosis requires medical evaluation by a qualified clinician.
For a deeper look at the early neurological signs of Parkinson’s disease, the Early Signs of Parkinson’s Disease article covers the full clinical picture including the prodromal features that can precede motor symptoms by years.
3. The Parkinsons Protocol — Overview
The Parkinsons Protocol is Blue Heron Health News’s digital lifestyle program for people with Parkinson’s disease. It is structured around the evidence-grounded position that lifestyle, dietary, and environmental factors meaningfully influence the course of Parkinson’s disease — specifically, that the oxidative stress, mitochondrial dysfunction, neuroinflammation, and gut-brain axis dysfunction that contribute to dopaminergic neuron degeneration can be addressed through disciplined lifestyle practice.
Who created it: The Parkinsons Protocol is a Blue Heron Health News publication. Blue Heron has been publishing lifestyle programs for chronic health conditions for over a decade, with a catalog spanning cardiovascular, metabolic, musculoskeletal, and neurological conditions.
Who it is for: People with a confirmed Parkinson’s disease diagnosis who are looking for a structured lifestyle framework to complement their conventional medical care. The program is also relevant for caregivers of people with Parkinson’s who want to understand the lifestyle and dietary strategies that can support the person they are caring for.
What it covers:
- Neuroprotective nutrition — dietary patterns targeting oxidative stress, which is a central mechanism in dopaminergic neuron death in Parkinson’s disease; the substantia nigra is particularly vulnerable to oxidative damage because dopamine metabolism itself generates reactive oxygen species as a byproduct
- Movement and exercise protocols — physical activity is one of the most evidence-supported lifestyle interventions for Parkinson’s disease; the program provides movement guidance specifically calibrated to the challenges of bradykinesia, tremor, and balance difficulties rather than generic exercise advice
- Mitochondrial health support — Complex I deficiency in the electron transport chain is a well-documented feature of Parkinson’s pathophysiology; the program incorporates nutritional strategies supporting mitochondrial function
- Dopamine-supportive nutrition — dietary precursor availability for dopamine synthesis and protein timing guidance relevant to levodopa medication effectiveness
- Gut-brain axis — Braak staging proposes that Lewy body pathology may originate in the gut’s enteric nervous system before spreading to the brainstem; gut health strategies have direct mechanistic relevance to Parkinson’s
- Sleep support — REM sleep behaviour disorder is common in Parkinson’s and often precedes motor symptoms; sleep quality is a meaningful component of the overall management approach
- Stress regulation — chronic stress activates neuroinflammatory pathways relevant to dopaminergic neuron health
Format: Digital PDF guide with immediate access after purchase. One-time purchase, no recurring fees.
Guarantee: Blue Heron’s standard 365-day money-back guarantee.
For the full module-by-module breakdown of what the program contains, the Parkinsons Protocol Review provides comprehensive contents analysis. For pricing details, see Parkinsons Protocol: Pricing and What You Get. If you want to assess the program’s credibility before purchasing, Is the Parkinsons Protocol a Scam or Legit? covers Blue Heron’s refund track record and buyer sentiment.
4. Neuropathy No More — Overview
Neuropathy No More is Blue Heron Health News’s digital lifestyle program for people with diabetic peripheral neuropathy. Like the Parkinsons Protocol, it follows Blue Heron’s root-cause philosophy — but its protocols are calibrated to the entirely different pathophysiology of metabolic peripheral nerve damage.
Who it is for: Adults with Type 2 diabetes who have developed — or are trying to prevent — peripheral neuropathy: the burning, tingling, and numbness in feet and hands caused by glucose toxicity damaging peripheral nerve fibers.
What it covers:
- Blood sugar regulation through dietary reform — the primary lever, because glucose toxicity is the primary cause; the dietary protocol targets refined carbohydrates, high-glycemic foods, and processed food patterns that drive chronically elevated HbA1c
- Circulatory support for peripheral nerves — because peripheral nerve damage in diabetes is fundamentally vascular, strategies improving peripheral circulation and endothelial health are directly relevant
- Nerve-repair nutritional support — alpha-lipoic acid (ALA), B vitamins (particularly B1/benfotiamine, B6, and B12), and vitamin D are nutrients with genuine research relevance to diabetic peripheral nerve health; multiple randomised controlled trials have demonstrated ALA’s ability to reduce neuropathic symptoms through antioxidant and nerve-repair mechanisms
- Anti-inflammatory dietary pattern — systemic inflammation accelerates vascular and neural damage in diabetes; the program’s anti-inflammatory dietary approach addresses this component
- Sleep and stress management — chronic stress and poor sleep worsen insulin resistance and systemic inflammation, compounding the metabolic environment driving neuropathy
Format: Digital PDF guide with immediate access after purchase. One-time purchase, no recurring fees.
Guarantee: Blue Heron’s standard 365-day money-back guarantee.
For the full detailed review of Neuropathy No More’s contents and approach, the Neuropathy No More Review provides the complete breakdown. For pricing information, see Neuropathy No More: Pricing and What You Get. For credibility assessment, Is Neuropathy No More a Scam or Legit? covers the purchase and refund experience in detail.
5. Head-to-Head Comparison
| Feature | Parkinsons Protocol | Neuropathy No More |
|---|---|---|
| Publisher | Blue Heron Health News | Blue Heron Health News |
| Target condition | Parkinson’s disease | Diabetic peripheral neuropathy |
| Disease location | Central brain (substantia nigra, basal ganglia) | Peripheral nerves (hands, feet, extremities) |
| Disease mechanism | Dopaminergic neuron degeneration (alpha-synuclein, oxidative stress, mitochondrial dysfunction) | Glucose toxicity damaging peripheral nerve vessels (vasa nervorum) |
| Primary symptom targets | Resting tremor, bradykinesia, rigidity, postural instability | Burning, tingling, numbness in extremities |
| Core approach | Neuroprotective nutrition, movement protocols, dopamine support, gut-brain axis | Blood sugar regulation, circulation, nerve-repair nutrients, anti-inflammatory diet |
| Key differentiator | Calibrated exercise protocols for Parkinson’s motor challenges | Glycemic management and ALA/B-vitamin nerve support |
| Evidence base | Strong (exercise for PD; Mediterranean diet; mitochondrial support) | Strong (glycemic control for neuropathy; SYDNEY trial; ALA trials) |
| Requires Parkinson’s diagnosis | Yes | No |
| Requires diabetes | No | Yes (diabetic neuropathy is diabetes-driven) |
| Who benefits most | PD patients + caregivers | T2D patients with neuropathy symptoms |
| Format | Digital download (PDF) | Digital download (PDF) |
| Price | ~$49 one-time | ~$49 one-time |
| Guarantee | 365 days (Blue Heron standard) | 365 days (Blue Heron standard) |
| Interchangeable? | No — condition-specific | No — condition-specific |
The key takeaway from this table: the programs are not competing alternatives for the same problem. They are condition-specific tools for different diagnoses. Almost everything that distinguishes them — mechanism, symptom target, core approach, exercise guidance — flows from the fundamental difference between the two conditions they serve.
6. Decision Tree: Which Should You Choose?
This is the section most readers need most. Use the decision tree below based on your actual diagnosis — not on symptom similarity or marketing framing.
Step 1: Do you have a formal medical diagnosis?
If yes — proceed to Step 2.
If no — stop here. If you are experiencing unexplained neurological symptoms — a hand tremor, burning feet, loss of balance, numbness — the first step is a medical evaluation, not a program purchase. A GP referral to a neurologist (for suspected Parkinson’s) or an endocrinologist/diabetes specialist (for suspected diabetic neuropathy) is required before you can correctly match any program to your situation. Neither program is a diagnostic tool.
Step 2: What is your diagnosis?
“I have been diagnosed with Parkinson’s disease” → Parkinsons Protocol is the appropriate program.
Your condition involves the progressive death of dopamine-producing neurons in your brain — not peripheral nerve damage from blood sugar. The Parkinsons Protocol’s neuroprotective nutrition, movement and exercise protocols calibrated to Parkinson’s motor challenges, mitochondrial support, and gut-brain axis strategies are designed for your specific pathophysiology. This is the program for you.
“I have Type 2 diabetes and have neuropathy symptoms — burning or tingling in my feet or hands” → Neuropathy No More is the appropriate program.
Your nerve symptoms are almost certainly diabetic peripheral neuropathy — a metabolic complication of your T2D. The most important thing you can do for your neuropathy is also the most important thing you can do for your diabetes: bring your HbA1c into target range and reduce the glucose toxicity damaging your peripheral nerve fibers. Neuropathy No More operates precisely in that territory. For additional context on managing blood sugar alongside neuropathy, How to Lower Blood Sugar Naturally and the Diabetic Neuropathy Treatment Guide provide useful foundational reading.
“I have neuropathy symptoms but no Parkinson’s diagnosis” → Neuropathy No More is more likely relevant — but get a diagnosis first.
Burning and tingling in the extremities point toward peripheral neuropathy. If you also have T2D, Neuropathy No More is likely the right program. However, peripheral nerve symptoms without a diabetes diagnosis can also indicate B12 deficiency, thyroid dysfunction, alcohol-related neuropathy, or other conditions — meaning Neuropathy No More’s blood-sugar-focused approach may not be relevant. Get diagnosed before selecting either program.
“I have a tremor but have not been formally diagnosed with Parkinson’s” → See a neurologist before purchasing the Parkinsons Protocol.
Tremor has multiple causes — essential tremor (the most common movement disorder, distinct from Parkinson’s), medication-induced tremor, thyroid disease, and others. The distinction between Parkinson’s disease and essential tremor in particular requires neurological evaluation; the two conditions are managed differently. Parkinsons Protocol is designed for confirmed Parkinson’s disease. Purchasing it before a confirmed diagnosis means you cannot properly apply its condition-specific protocols.
“I have both Type 2 diabetes with neuropathy AND Parkinson’s disease” → Both programs may be relevant for two separate conditions.
In this uncommon but possible scenario, Neuropathy No More addresses the diabetic neuropathy component and Parkinsons Protocol addresses the Parkinson’s component. Their condition-specific protocols are genuinely different and non-redundant. You would not be duplicating effort — you would be addressing two distinct conditions with the correct tool for each.
“I am a caregiver for someone with Parkinson’s disease” → Parkinsons Protocol is the relevant resource.
The Parkinsons Protocol is valuable not only for people with Parkinson’s directly but for caregivers who want to understand the dietary, lifestyle, and movement strategies they can support and implement alongside the person they care for. The program’s education-first approach makes it accessible to family members and caregivers as well as patients. For the broader neurological context across Blue Heron’s program catalog, the Multiple Sclerosis vs Parkinsons Protocol comparison provides useful perspective on how different neurological conditions map to different programs. The MS Symptoms: Early Warning Signs article also covers the neurological landscape in more depth.
Get the Parkinsons Protocol — 365-Day Guarantee
7. What the Evidence Says About Each Approach
Both programs draw from genuine published research literature. Understanding the evidence base helps you evaluate each program honestly.
Parkinsons Protocol: The Evidence Pillars
Exercise as a disease-modifying strategy. This is the strongest single evidence strand for the Parkinsons Protocol’s approach. Physical activity in Parkinson’s disease is one of the most consistently studied lifestyle interventions in the neurological literature. A Cochrane review of exercise for Parkinson’s disease concluded that exercise improves gait, balance, motor function, and quality of life. Animal studies have shown that exercise increases brain-derived neurotrophic factor (BDNF) in dopaminergic circuits and promotes neuroplasticity. A landmark JAMA Neurology study demonstrated that forced-rate cycling improved motor function in people with Parkinson’s, with effects comparable to voluntary cycling at higher intensities — pointing to the relevance of exercise intensity and structure for this population.
Neuroprotective nutrition and Mediterranean diet. Research examining the Mediterranean diet and Parkinson’s risk has found associations between anti-inflammatory, antioxidant-rich dietary patterns and both reduced Parkinson’s risk and slower disease progression. The antioxidant capacity of this dietary pattern is particularly relevant given the substantia nigra’s high vulnerability to oxidative damage.
Mitochondrial support. Complex I deficiency in the electron transport chain is a well-replicated finding in Parkinson’s disease pathophysiology. Research from multiple groups has found reduced Complex I activity in substantia nigra neurons of Parkinson’s patients. CoQ10 has been investigated in several Parkinson’s trials as a neuroprotective agent, with mixed but biologically plausible results.
The gut-brain axis. Braak staging evidence suggests that Lewy body pathology may begin in the gut’s enteric nervous system before spreading to the brainstem — giving gut health strategies a more direct mechanistic relevance to Parkinson’s than to most other neurological conditions. Gut microbiome composition differs between Parkinson’s patients and healthy controls, and vagotomy studies have suggested that the vagal route from gut to brain may be the pathway for alpha-synuclein spread in some cases.
Neuropathy No More: The Evidence Pillars
Glycemic control as the primary lever. The Diabetes Control and Complications Trial (DCCT) demonstrated that intensive glycemic control reduced the development of neuropathy by 60% in Type 1 diabetics — and subsequent evidence in Type 2 diabetes has reinforced the same principle. HbA1c management is the single most evidence-supported intervention for slowing diabetic peripheral neuropathy progression. This is the foundation of Neuropathy No More’s approach.
Alpha-lipoic acid (ALA). The SYDNEY trial (published in Diabetes Care) is one of the most cited studies in diabetic neuropathy research. It demonstrated that intravenous ALA significantly reduced neuropathic symptoms. Subsequent oral ALA trials have also shown symptom reduction benefits. ALA is an antioxidant that can regenerate other antioxidants (vitamin C, vitamin E) and has direct relevance to peripheral nerve oxidative damage.
B vitamins for nerve metabolism. B12 deficiency is common in people with Type 2 diabetes (particularly those taking metformin) and is independently associated with peripheral neuropathy. Benfotiamine (a fat-soluble form of vitamin B1) has been studied specifically in diabetic neuropathy and has demonstrated reductions in neuropathic pain and nerve damage biomarkers. B6 is a cofactor in multiple nerve metabolism pathways. The B-vitamin evidence base is well-established for this population.
Anti-inflammatory dietary patterns. Systemic inflammation — driven by poor dietary quality, excess processed food, and high refined carbohydrate intake — accelerates the vascular and neural damage of diabetic neuropathy. Anti-inflammatory dietary approaches have both direct nerve-health relevance and indirect benefit through improved insulin sensitivity and reduced HbA1c.
8. Our Verdict
The Parkinsons Protocol and Neuropathy No More serve genuinely different populations. For most readers, this is not an either/or choice — diagnosis determines the answer.
If you have Parkinson’s disease: The Parkinsons Protocol is the right program. Its evidence-based movement protocols, neuroprotective nutritional approach, mitochondrial support strategies, and gut-brain axis focus are calibrated to the specific biology of dopaminergic neurodegeneration. Blue Heron has built a program that takes the non-motor features of Parkinson’s seriously — sleep, mood, gut health, dietary precursor availability — not just the tremor. For people who have received a Parkinson’s diagnosis and want a structured lifestyle framework to complement their neurological care, this is the relevant resource.
The program is realistic about what lifestyle approaches can and cannot do: it is not a cure, it does not arrest neurodegeneration, and it does not replace carbidopa/levodopa or the oversight of a neurologist or movement disorder specialist. What it provides is the lifestyle layer of Parkinson’s management — the dietary, movement, sleep, and stress-management dimensions that clinical appointments rarely have time to address in depth.
If you have diabetic peripheral neuropathy: Neuropathy No More is the right program. Its blood-sugar-first approach, ALA and B-vitamin nutritional guidance, and circulatory support strategies address the actual mechanism of diabetic peripheral nerve damage. The program will not reverse significant existing nerve fiber loss — that requires consistent metabolic management over years — but it provides a structured framework for the lifestyle dimensions of neuropathy management.
If you are unsure of your diagnosis: Seek medical evaluation before purchasing either program. A resting tremor that has not been evaluated neurologically, or burning feet without a diabetes workup, require diagnosis before program selection. Neither program is a diagnostic tool, and using the wrong program for the wrong condition means receiving guidance that simply does not apply to your situation.
On the 365-day guarantee for both: At approximately $49 each with a full year to evaluate and request a refund, either program is a low-stakes purchase decision once you have confirmed the applicable diagnosis. Blue Heron’s 365-day window is notably more generous than the standard 60-day ClickBank guarantee — particularly important for slowly progressing conditions like Parkinson’s and diabetic neuropathy, where meaningful lifestyle outcomes take months of consistent practice to assess.
Try the Parkinsons Protocol Risk-Free — 365-Day Guarantee
9. Frequently Asked Questions
What is the difference between Parkinson’s disease and peripheral neuropathy?
Parkinson’s disease and peripheral neuropathy are completely different conditions despite both involving nerve-related symptoms. Parkinson’s disease is a progressive neurodegenerative condition affecting dopamine-producing neurons in the brain’s substantia nigra. It causes central motor symptoms: resting tremor (typically beginning in one hand), bradykinesia (slowness of movement), muscular rigidity, and postural instability. Peripheral neuropathy — specifically diabetic peripheral neuropathy, which is what Neuropathy No More addresses — is damage to peripheral nerves outside the brain and spinal cord. It is caused by glucose toxicity in Type 2 diabetes damaging the tiny blood vessels that supply the nerves in the feet and hands. Its symptoms are burning pain, tingling, numbness, and loss of sensation in the extremities. The two conditions have different mechanisms, different anatomical locations, and different management priorities.
Which program is right for me — Parkinsons Protocol or Neuropathy No More?
The answer is almost entirely determined by your diagnosis. If you have a confirmed Parkinson’s disease diagnosis, the Parkinsons Protocol is the appropriate program. If you have Type 2 diabetes with peripheral neuropathy symptoms (burning, tingling, or numbness in your feet or hands), Neuropathy No More is the appropriate program. If you have both conditions, both programs may be relevant — they address genuinely different disease processes and are not redundant. If you are unsure of your diagnosis, the priority is a medical evaluation before selecting either program. A tremor that has not been evaluated neurologically, or peripheral nerve symptoms without a diabetes workup, require diagnosis before program selection.
Can I have both Parkinson’s disease and peripheral neuropathy?
Yes. Type 2 diabetes and Parkinson’s disease are independent conditions that can coexist in the same person — one does not exclude the other. A person who has T2D with diabetic peripheral neuropathy can also develop Parkinson’s disease. In that scenario, both programs may be relevant because they address different disease processes. Neuropathy No More addresses the blood sugar, circulation, and nerve-repair dimensions of diabetic peripheral neuropathy. The Parkinsons Protocol addresses the dopaminergic support, neuroprotective nutrition, and movement-focused dimensions of Parkinson’s disease. Their condition-specific protocols are genuinely different and non-redundant.
Are both programs from Blue Heron?
Yes — both the Parkinsons Protocol and Neuropathy No More are published by Blue Heron Health News, the same digital health publisher. Blue Heron has been producing lifestyle and informational health programs for over a decade. Both programs follow Blue Heron’s consistent philosophy: lifestyle and dietary factors meaningfully influence the course of chronic conditions, and addressing root-cause mechanisms — rather than downstream symptoms alone — is the most effective lifestyle approach. Both programs are digital PDF guides available as one-time purchases with immediate access.
Do both programs have a money-back guarantee?
Yes — both the Parkinsons Protocol and Neuropathy No More carry Blue Heron Health News’s standard 365-day money-back guarantee. This is a full calendar year from the date of purchase — significantly more generous than the standard 60-day window offered by most digital health programs. If you purchase either program and are not satisfied for any reason within one year, you can request a full refund through Blue Heron’s customer support. This guarantee applies equally to both programs and represents a genuinely low-risk purchase decision.
Check the Current Price on the Official Website
This article is for educational purposes only and does not constitute medical advice. The Parkinsons Protocol and Neuropathy No More are informational lifestyle programs, not treatments, medications, or medical devices. Parkinson’s disease and diabetic peripheral neuropathy are serious medical conditions that require diagnosis and ongoing management by qualified healthcare professionals — a neurologist or movement disorder specialist for Parkinson’s disease, and an endocrinologist or diabetes care team for diabetic neuropathy. Nothing in this article constitutes a diagnosis, a treatment recommendation, or advice to modify, reduce, or discontinue prescription medications. Always consult your doctor before making significant changes to your diet, supplementation, or lifestyle when managing a diagnosed health condition.
Nora Hartwell is a practitioner of traditional and self-reliant health approaches, not a licensed clinician. Nothing on this site constitutes a diagnosis or treatment recommendation. See our about page and disclosure page for full context.